PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL
https://doi.org/10.20538/1682-0363-2015-6-81-86
Abstract
Pharmacoepidemiological and pharmacoeconomical analysis of endometrit drug therapy at special treatment-and-prophylactic institutions of the city of Tomsk. Estimate the intensity of the appointment of antibacterial drugs endometrit therapy using the methodology of the WHO ATC/DDD, calculated indicators of the intensity of the consumption of drugs in the course of treatment per patient. It was shown that 70% of the established daily dose had to beta-lactam antibiotics and macrolide. For the most common options for antibiotic therapy established nosology of the indicators of clinical efficacy. The calculation of the cost of the schemes of antibiotic therapy, which showed that the cost of treatment is maximal during therapy with ceftriaxone + clarithromycin (4902 RUR); further descending follow: amoxicillin / clavulanic acid + roxithromycin (4658 RUR); benzylpenicillin and gentamicin (4231 RUR). Economic efficiency of antibacterial treatments endometritis a
“cost – effectiveness”. The cost of the patient, achieved remission, made during therapy with amoxicillin/clavulanic acid and roxithromycin (5416 RUR), During therapy with ceftriaxone and clarithromycin (6052 RUR), the treatment of benzylpenicillin and gentamicin (14420 RUR). Pharmacoeconomic evaluation results showed that the least acceptable scheme of antibacterial therapy
of endometrit in the hospital is the combination of benzyl penicillin and gentamicin. Тhe antibiotic therapy for endometrit may be recommended by a combination of amoxicillin / clavulanic acid and
roxithromycin and clarithromycin and ceftriaxone, for which there was no statistically significant differences in clinical efficacy and cost of antibiotic therapy.
About the Authors
L. Yu. Chernikova
Siberian State Medical University, Tomsk, Russian Federation
Russian Federation
Siberian State Medical University, Tomsk, Russian Federation Ph. +7-913-800-6909
Russian Federation
Siberian State Medical University, Tomsk, Russian Federation Ph. +7-913-800-6909
M. V. Belousov
Siberian State Medical University, Tomsk, Russian Federation
Russian Federation
Siberian State Medical University, Tomsk, Russian Federation
Russian Federation
Siberian State Medical University, Tomsk, Russian Federation
References
1. Dovgan Ye.V., Rafalsky V.V. Primenenie antibakterialnyh preparatov v akushersko ginekologicheskoy praktike v Rosiyskoy Federacii: brendy vs generiki [The use of antimicrobials in obstetric practice in Russian Federation: brands vs generics]. Biomedicina – Biomedical, 2010, vol. 1, no. 4, pp. 82–87 (in Russian).
2. Pitt C., Sanchez-Ramos L., Kaunitz A.M. Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. Obstetrics and Gynecology, 2001, no. 98, pp. 745–750.
3. Karakulova Ye.V., Loskutova Ye.Ye., Ushkalova Ye.A. Menedzhment lekarstvennoy pomochi-covremennaya paradigma farmacevticheskoy praktiki [Medicines management – modern paradigm for fharmacy practice]. Byulleten' sibirskoy meditsiny – Bulletin of Siberian Medicine, 2012, vol. 11, no. 6, pp. 119–125 (in Russian).
4. Yаgudina R.I., Serpik V.G., Kulikov A.Yu. Farmakoehkonomika dlya organizatorov zdravoohraneniya Algoritm prinyatiya reshenij na osnove farmakoehkonomicheskoj ocenki [Pharmacoeconomics for policy-makers. Algorithm-based decision pharmacoeconomic evaluation]. Farmakoekonomika – Pharmacoeconomics, 2014, no. 1, pp. 5–12 (in Russian).
5. Yakusheva Ye.N. Optimizatiya otbora lekarstvennyh sredstv v formulyarnye perechni na osnove garmonizatii norvativnyh dokumentov, kliniko-farmakologicheckogo i farmakoekonomicheskogo analiza. Avtoref. dis. dokt. med. nauk [Optimization of selection of drugs in the formulary lists based on harmonization of regulations, clinical and pharmacological and pharmaco-economic analysis. Author. dis. MD.]. Moscow, 2009. P. 3 (in Russian).
6. WHO Collaborating Centre for Drug Statistics Methodology. URL: http:// www.whocc.no/ atc ddd (accessed 30. November 2014).
7. Postanovlenie administracii Tomskoy oblasti ot 25 dekabrya 2013 no. 572 “Ob utverzhdenii oblastnoy programmy gosudarstvennyh garantiy besplatnogo okazaniya grazhdanam Rossijskoy Federacii medicinskoy pomoshchi na territorii Tomskoy oblasti na 2014 god” [Resolution the administration of the Tomsk region on 25 December 2013 no. 572 “On approval of the regional program of state guarantees of free provision citizens of the Russian Federation medical care in the Tomsk region in 2014.”] (in Russian).
8. Rudakova A.V., Hveshchuk P.F. Sovremennaya farmakoterapiya dokazatelstvo ehffektivnosti [Modern pharmacotherapy: proof of efficacy]. St. Petersburg, VMedA Publ., 2002. 256 p. (in Russian).
9. Rafalsky V.V., Dovgan Ye.V., Ivanyan A.N., Sawicky А.N. Praktika primeneniya antimikrobnyh preparatov u zhenchin c vocpalitelnymi zabolevaniajmi organov malogo taza v Rossiyskoy Federacii [The practice of using antimicrobial agents in women with inflammatory diseases of the pelvic organs in the Russian Federation]. Akusherstvo i ginekologiya – Obstetrics and Gynecology, 2011, no. 5, pp. 88–93 (in Russian).
10. Rebrova O.Yu. Statisticheskiy analiz medicinskih dannyh Primenenie paketa prikladnyh programm Statistica [Statistical analysis of medical data. The use of the application package STATISTICA]. Moscow, Media Sfera Publ., 2006. 312 p. (in Russian).
Review
For citations:
Chernikova L.Yu., Belousov M.V. PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL. Bulletin of Siberian Medicine. 2015;14(6):81-86. (In Russ.) https://doi.org/10.20538/1682-0363-2015-6-81-86
Views:
1123
Email this article 